ManuPharma 2017

December 06-December 07, 2017

Steigenberger Frankfurter Hof, Frankfurt

Contact Us: 44 (0) 207 036 1363

Jean Philippe Giraud

Director, Head of Technical Transfers, Global Manufacturing & Supply
Merck Serono
Jean-Philippe leads the implementation of all technical transfers for Merck's global pharma organisation. His current remit includes 40 transfers ongoing around the global, leading a team of seven technical transfer managers and a PMO manager. His key focuses are upon supporting pharma reliability and volume growth by executing CMO and internal dual sourcing strategy, localisaing manufacturing operations where possible to maintain market access (particularly in emerging markets) and supporting supply flexibility andd scalability.


12:10 PM FIRESIDE CHAT Why pharma must embrace Continuous Manufacturing in order to optimise efficiency and reduce costs

FOR
·         The capabilities of continuous manufacturing technology, following recent advancements, allow for successful production of the full range of small molecule and biologics, with improved efficiency
AGAINST:
·         Continuous manufacturing technology is not yet advanced enough to successfully manufacture a full range of pharmaceutical products (small molecule through to biologics) successfully, cost effectively and compliantly
FOR: Craig Johnston, Industrial  Director, CMAC
Craig is Industry Director at (CMAC) Continuous Manufacturing and Crystallisation. He works with industry including tier 1 multi nationals eg GSK, AZ, Novartis, Bayer and technology companies. Established in 2011, CMAC now has 120 staff across its network of 7 leading universities. It conducts leading research in continuous manufacturing with particle focus
AGAINST: Jean Philippe Giraud, Director, Head of Technical Transfers, Global Manufacturing & Supply, Merck Serono
Jean-Philippe leads the implementation of all technical transfers for Merck's global pharma organisation. His current remit includes 40 transfers ongoing around the global, leading a team of seven technical transfer managers and a PMO manager. His key focuses are upon supporting pharma reliability and volume growth by executing CMO and internal dual sourcing strategy, localising manufacturing operations where possible to maintain market access (particularly in emerging markets) and supporting supply flexibility add scalability